Menu
GeneBe

11-64116305-C-G

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_013280.5(FLRT1):c.38C>G(p.Thr13Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00152 in 1,606,438 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T13M) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00079 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0016 ( 4 hom. )

Consequence

FLRT1
NM_013280.5 missense

Scores

1
1
13

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:3

Conservation

PhyloP100: 1.45
Variant links:
Genes affected
FLRT1 (HGNC:3760): (fibronectin leucine rich transmembrane protein 1) This gene encodes a member of the fibronectin leucine rich transmembrane protein (FLRT) family. The family members may function in cell adhesion and/or receptor signalling. Their protein structures resemble small leucine-rich proteoglycans found in the extracellular matrix. The encoded protein shares sequence similarity with two other family members, FLRT2 and FLRT3. This gene is expressed in kidney and brain. [provided by RefSeq, Jul 2008]
MACROD1 (HGNC:29598): (mono-ADP ribosylhydrolase 1) Enables ADP-ribosylglutamate hydrolase activity and deacetylase activity. Involved in cellular response to DNA damage stimulus; peptidyl-glutamate ADP-deribosylation; and purine nucleoside metabolic process. Located in nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.015900493).
BS2
High Homozygotes in GnomAdExome at 2 gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
FLRT1NM_013280.5 linkuse as main transcriptc.38C>G p.Thr13Arg missense_variant 3/3 ENST00000682287.1
MACROD1NM_014067.4 linkuse as main transcriptc.517+34934G>C intron_variant ENST00000255681.7

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
FLRT1ENST00000682287.1 linkuse as main transcriptc.38C>G p.Thr13Arg missense_variant 3/3 NM_013280.5 P1
MACROD1ENST00000255681.7 linkuse as main transcriptc.517+34934G>C intron_variant 1 NM_014067.4 P4

Frequencies

GnomAD3 genomes
AF:
0.000788
AC:
120
AN:
152236
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000169
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.000576
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000828
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00154
Gnomad OTH
AF:
0.000478
GnomAD3 exomes
AF:
0.000876
AC:
206
AN:
235092
Hom.:
2
AF XY:
0.000960
AC XY:
123
AN XY:
128072
show subpopulations
Gnomad AFR exome
AF:
0.000331
Gnomad AMR exome
AF:
0.000119
Gnomad ASJ exome
AF:
0.000916
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00118
Gnomad FIN exome
AF:
0.0000573
Gnomad NFE exome
AF:
0.00140
Gnomad OTH exome
AF:
0.000684
GnomAD4 exome
AF:
0.00160
AC:
2329
AN:
1454084
Hom.:
4
Cov.:
30
AF XY:
0.00162
AC XY:
1174
AN XY:
723344
show subpopulations
Gnomad4 AFR exome
AF:
0.000240
Gnomad4 AMR exome
AF:
0.000113
Gnomad4 ASJ exome
AF:
0.00104
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00116
Gnomad4 FIN exome
AF:
0.0000608
Gnomad4 NFE exome
AF:
0.00190
Gnomad4 OTH exome
AF:
0.00128
GnomAD4 genome
AF:
0.000788
AC:
120
AN:
152354
Hom.:
0
Cov.:
33
AF XY:
0.000778
AC XY:
58
AN XY:
74506
show subpopulations
Gnomad4 AFR
AF:
0.000168
Gnomad4 AMR
AF:
0.0000653
Gnomad4 ASJ
AF:
0.000576
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000829
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00154
Gnomad4 OTH
AF:
0.000473
Alfa
AF:
0.000503
Hom.:
0
Bravo
AF:
0.000737
TwinsUK
AF:
0.00108
AC:
4
ALSPAC
AF:
0.00285
AC:
11
ESP6500AA
AF:
0.000455
AC:
2
ESP6500EA
AF:
0.00140
AC:
12
ExAC
AF:
0.000775
AC:
94

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsNov 06, 2023The c.38C>G (p.T13R) alteration is located in exon 2 (coding exon 1) of the FLRT1 gene. This alteration results from a C to G substitution at nucleotide position 38, causing the threonine (T) at amino acid position 13 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Peripheral neuropathy Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingInvitaeAug 09, 2022This sequence change replaces threonine, which is neutral and polar, with arginine, which is basic and polar, at codon 13 of the FLRT1 protein (p.Thr13Arg). This variant is present in population databases (rs139768227, gnomAD 0.1%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with FLRT1-related conditions. ClinVar contains an entry for this variant (Variation ID: 461801). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Not Available"; Align-GVGD: "Class C0"). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not provided Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenMay 01, 2016- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.47
T
BayesDel_noAF
Benign
-0.47
Cadd
Benign
21
Dann
Benign
0.95
Eigen
Benign
-0.11
Eigen_PC
Benign
-0.17
FATHMM_MKL
Benign
0.57
D
M_CAP
Benign
0.047
D
MetaRNN
Benign
0.016
T
MetaSVM
Benign
-0.89
T
MutationTaster
Benign
0.96
D;N
PrimateAI
Benign
0.36
T
PROVEAN
Benign
-0.040
N
REVEL
Benign
0.088
Sift
Pathogenic
0.0
D
Sift4G
Uncertain
0.042
D
Vest4
0.29
MVP
0.32
MPC
0.33
ClinPred
0.062
T
GERP RS
4.5
gMVP
0.60

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs139768227; hg19: chr11-63883777; API